Literature DB >> 31926488

Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?

Yukihiro Terada1, Mitsuhiro Isaka1, Hideyuki Harada2, Hayato Konno1, Hideaki Kojima1, Tetsuya Mizuno1, Shigeyuki Murayama3, Toshiaki Takahashi4, Yasuhisa Ohde1.   

Abstract

BACKGROUND: There is no standard therapeutic approach for local recurrence of non-small cell lung cancer (NSCLC) after complete resection. We investigated the outcomes of radiotherapy (RT) for patients with local recurrence.
METHODS: We reviewed 46 patients who underwent curative-intent RT for local recurrence after lobectomy or pneumonectomy accompanied with mediastinal lymph node dissection between 2002 and 2014. We analyzed overall survival (OS), progression-free survival (PFS), local control, tumour response and the re-recurrence pattern.
RESULTS: Among the 46 patients, 16 received concurrent chemotherapy. The median follow-up period was 48 months. The response rate was 91%. The 5-year OS and local control rates were 47.9 and 65.3%, respectively, and the 5-year PFS rate was 22.8%. Female sex and complete response to radiation were favourable prognostic factors. Of the 33 patients with recurrence after radiation, 32 (97%) had distant metastasis.
CONCLUSIONS: Although RT for local recurrence has high efficacy, distant relapse after radiation remains a major issue. Therefore, combination systemic therapy for local recurrence at any site should be further investigated. Since it is difficult to achieve a radical cure for local recurrence using RT, further study, for the administration of post-operative adjuvant therapy, is recommended.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  chemoradiotherapy; complete resection; neoplasm metastasis; neoplasm recurrence; non-small cell lung carcinoma

Mesh:

Year:  2020        PMID: 31926488     DOI: 10.1093/jjco/hyz188

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.

Authors:  Mitsuhiro Isaka; Hideaki Kojima; Toru Imai; Hayato Konno; Tetsuya Mizuno; Toshiyuki Nagata; Shinya Katsumata; Takuya Kawata; Takashi Nakajima; Yasuhisa Ohde
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-05-11

2.  Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC.

Authors:  Paolo Borghetti; Jessica Imbrescia; Giulia Volpi; Vieri Scotti; Michele Aquilano; Alessio Bruni; Davide Franceschini; Stefano Ursino; Patrizia Ciammella; Gaia Piperno; Maria Taraborrelli; Stefano Maria Magrini
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

3.  Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer.

Authors:  Wen-Cai Li; Zhen Wang; Jie Gao; Han Zhou; Jing Li; Xi-Xu Zhu
Journal:  Cancer Manag Res       Date:  2021-02-23       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.